Getein Biotech, Inc (SHA:603387)
China flag China · Delayed Price · Currency is CNY
8.75
0.00 (0.00%)
At close: Jan 23, 2026

Revenue by Product

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Point of Care Testing Conventional Series
620.59M
Log In
Log In
Log In
Log In
Upgrade
Point of Care Testing Conventional Series Growth
-16.10%
Log In
Log In
Log In
Log In
Upgrade
Chemiluminescence Series
265.18M
Log In
Log In
Log In
Log In
Upgrade
Chemiluminescence Series Growth
31.14%
Log In
Log In
Log In
Log In
Upgrade
Three Inspections, Copperative Construction and Others
167.04M
Log In
Log In
Log In
Log In
Upgrade
Three Inspections, Copperative Construction and Others Growth
-38.84%
Log In
Log In
Log In
Log In
Upgrade
Biochemistry, Hematology and Others
106.70M
Log In
Log In
Log In
Log In
Upgrade
Biochemistry, Hematology and Others Growth
-12.77%
Log In
Log In
Log In
Log In
Upgrade
Point of Care Testing COVID-19 Series
5.28M
Log In
Log In
Log In
Log In
Upgrade
Point of Care Testing COVID-19 Series Growth
-83.40%
Log In
Log In
Log In
Log In
Upgrade
In Vitro Diagnosis
-
Log In
Log In
Log In
Log In
Upgrade
In Vitro Diagnosis Growth
-
Log In
Log In
Log In
Log In
Upgrade
Agency and Other
-
Log In
Log In
Log In
Log In
Upgrade
Agency and Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Testing Service
-
Log In
Log In
Log In
Log In
Upgrade
Testing Service Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
China
1.02B
Log In
Log In
Log In
Log In
Upgrade
China Growth
-16.91%
Log In
Log In
Log In
Log In
Upgrade
Overseas
142.44M
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
2.63%
Log In
Log In
Log In
Log In
Upgrade